Reproducibility of cognitive endpoints in clinical trials: Lessons from neurofibromatosis type 1

Authors

Jonathan M Payne, University of Melbourne
David H Gutmann, Washington University School of Medicine in St. Louis
et al

Journal

Annals of Clinical and Translational Neurology

Publication Date

12-1-2019

Volume

6

Issue

12

First Page

2555

Last Page

2565

Document Type

Open Access Publication

DOI

10.1002/acn3.50952

Rights and Permissions

Payne, J.M., Hearps, S.J.C., Walsh, K.S., Paltin, I., Barton, B., Ullrich, N.J., Haebich, K.M., Coghill, D., Gioia, G.A., Cantor, A., Cutter, G., Tonsgard, J.H., Viskochil, D., Rey‐Casserly, C., Schorry, E.K., Ackerson, J.D., Klesse, L., Fisher, M.J., Gutmann, D.H., Rosser, T., Packer, R.J., Korf, B., Acosta, M.T., North, K.N. and (2019), Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. Ann Clin Transl Neurol, 6: 2555-2565. doi:10.1002/acn3.50952 © 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

Recommended Citation

Payne, Jonathan M; Gutmann, David H; and et al, "Reproducibility of cognitive endpoints in clinical trials: Lessons from neurofibromatosis type 1." Annals of Clinical and Translational Neurology. 6, 12. 2555 - 2565. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8616